Evidence map›Paper›PMID 42541663›Full record

ArticleInternational urology and nephrology2026

Machine learning-based prediction of Clavien-Dindo ≥ II complications after ureteroscopy.

Miroslav Stojadinović, Slobodan Janković

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Miroslav StojadinovićFaculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia. midinac@gmail.com.ORCID http://orcid.org/0000-0002-5215-8729
Slobodan JankovićFaculty of Medical Sciences, Pharmacology and Toxicology Department, University of Kragujevac, Kragujevac, Serbia.ORCID http://orcid.org/0000-0002-1519-8828

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeClavien-Dindo (CD) grade II complications after ureteroscopy occur in approximately 13-17% of cases, typically involving infections or bleeding requiring medical intervention. Thus, the purpose of this study was to create and internally validate a lean prediction model for CD ≥ II complications after ureteroscopy using routinely available perioperative predictors.

methodsRetrospective study of ureteroscopic lithotripsy patients (2010-2014) evaluated outcomes and risk factors. Covariates included age, stone size, operative time, status of impacted stones, and the presence of a percutaneous nephrostomy (PN). The performance of the discriminative models was evaluated using the area under the receiver operating characteristic curve (AUC) with 95% confidence intervals. Overall model performance was further assessed in terms of discrimination, calibration, and accuracy, while clinical utility was evaluated using decision curve analysis. Model explainability was addressed through variable importance measures and complementary interpretability techniques.

resultsA total of 389 patients were included, of whom 8.5% experienced clinically significant complications. The binomial generalized linear model (GLM) with Elastic Net regularization and the gradient boosting model (GBM) were developed using an 80:20 train-test split. In the testing dataset, both models demonstrated excellent discrimination (GLM AUC 0.893 vs. GBM AUC 0.857; p = 0.672). Calibration demonstrated strong performance, and decision curve analysis confirmed that both models outperformed treat-all and treat-none strategies, with GBM showing a modest advantage. Operative time and impacted stones were key predictors. DISCUSSION: By integrating routinely available perioperative variables, the model enables individualized risk stratification and may support preoperative counseling and clinical decision-making.

Indexed as

ComplicationsLithotripsyMachine learningRisk factorsSHAP (Shapley additive explanations)UroStone

Identifiers

PMID42541663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.